Troutman Pepper advised Botanix Pharmaceuticals Limited on the deal. Botanix Pharmaceuticals Limited (ASX: BOT), a clinical dermatology company, has announced the acquisition of Sofpironium Bromide gel,...
This content is for Standard 1 Year members only. LoginJoin Now